What Is a Forest Plot?
A forest plot is a graph used in meta-analysis to display the results of multiple individual studies on the same research question, side by side, along with a single combined ("pooled") result at the bottom. Each row represents one study; a vertical line running through the whole plot marks the point of "no effect"; and each study's result is drawn as a square with a horizontal line through it, showing both its estimated effect and how precise that estimate is.
The name comes from its appearance — a column of horizontal lines can resemble a forest of trees viewed from a distance, an image that stuck in the epidemiology literature decades ago and never left.
Why Is a Forest Plot Used?
A forest plot solves a real problem: a systematic review might identify ten different studies on the same question, each with a different sample size, a slightly different estimate, and its own uncertainty — reading ten separate results in a table is hard to synthesize at a glance. A forest plot lets a reader instantly see, in one image, whether the studies broadly agree with each other, how much each one contributed to the final answer, and what the combined evidence concludes.
It also makes transparent exactly what a meta-analysis is doing mathematically: pooling several imprecise individual estimates into one more precise combined estimate, which is the entire logic behind why meta-analyses are considered high-quality evidence — more studies, thoughtfully combined, generally narrow the uncertainty around the true effect.
Forest plots also make a meta-analysis auditable in a way a paragraph of prose cannot. A reader can check, without re-running any statistics, whether the pooled conclusion actually reflects what the individual studies show, whether one enormous study is silently dominating the result, or whether the studies genuinely disagree with each other beneath a seemingly tidy pooled number — this transparency is a large part of why systematic reviews sit at the top of most evidence hierarchies used in clinical guideline development.
Every Part of a Forest Plot, Explained
Below is a fully labeled, realistic example forest plot from a meta-analysis of five randomized trials comparing a new drug to placebo, using the odds ratio (OR) as the effect measure. Study through each element using the table underneath it, then look back at the plot until every piece makes sense.
Test for overall effect: Z = 4.12 (p < 0.001)
| Element | What It Shows You |
|---|---|
| Study names | The first author and year of each included study, one per row, usually ordered alphabetically, by year, or by weight. |
| Effect size | The point estimate for that study (here, an odds ratio) — the center of its square, and the number printed in the right-hand column. |
| Confidence interval | The horizontal line through each square — its left and right ends mark the lower and upper bounds of that study's 95% CI. |
| Squares | Mark each study's point estimate. Their size is proportional to that study's weight in the pooled analysis. |
| Horizontal lines | Represent each study's confidence interval — longer lines mean less precise (more uncertain) individual results. |
| Diamond | Represents the pooled (combined) effect across all studies. Its center is the pooled estimate; its width is the pooled 95% CI. |
| Weight | The percentage contribution of each study to the pooled estimate — driven mainly by precision, not just sample size. |
| Line of no effect | The vertical reference line at the value representing "no difference" (OR/RR/HR = 1, or MD/SMD = 0). |
| Overall effect | The pooled estimate and its CI, shown as the diamond and printed in the bottom row — the meta-analysis's headline result. |
| Heterogeneity | A statistic (usually I²) shown in a caption below the plot, describing how much the true effect appears to vary across studies. |
Fixed-Effect Forest Plot
A fixed-effect model assumes that every included study is estimating the exact same true underlying effect, and that any differences between study results are due purely to random sampling error (chance), not genuine differences between the studies. This is a reasonable assumption when the included studies are clinically and methodologically similar — same population, same intervention, same outcome definition.
The example plot above uses a fixed-effect model: notice the low heterogeneity (I² = 0%, meaning essentially none of the variation between study results is beyond what chance alone would explain) and the correspondingly narrow diamond, since a fixed-effect model only needs to account for within-study sampling error when calculating the pooled CI.
Random-Effects Forest Plot
A random-effects model instead assumes that the true effect genuinely varies from study to study — perhaps due to different populations, dosages, or follow-up durations — and that each study is estimating its own slightly different true effect, drawn from a distribution of plausible true effects. This model adds an extra layer of uncertainty (between-study variance) on top of ordinary sampling error, which is why random-effects pooled estimates almost always have a wider confidence interval than a fixed-effect analysis of the same data.
The example below shows a random-effects meta-analysis of five trials measuring the mean difference (MD) in systolic blood pressure with a new therapy versus control. Notice the substantial heterogeneity (I² = 73%) and the visibly wider diamond compared to the fixed-effect example above, even though both plots pool five studies of a similar size.
Test for overall effect: Z = 3.71 (p < 0.001)
Interpreting Statistically Significant Results
A pooled result is statistically significant when the diamond does not touch the vertical line of no effect — its entire width lies on one side of that line. In the fixed-effect OR example above, the diamond (0.64, 95% CI 0.53–0.78) sits entirely to the left of OR = 1, meaning the drug significantly reduced the odds of the outcome compared to placebo.
Individual studies can also be significant on their own — notice Okafor et al. 2020 (0.48, 95% CI 0.29–0.79) does not cross the line either — but a pooled result being significant does not require every individual study to be significant on its own; several individually non-significant studies can still combine into a significant pooled result once their precision is pooled together.
Interpreting Non-Significant Results
A result is not statistically significant when its line (for a study) or diamond (for the pooled estimate) touches or crosses the line of no effect — the data are consistent with the true effect being null, protective, or harmful, and the study or meta-analysis cannot distinguish between those possibilities with confidence.
A non-significant individual study is extremely common and expected within a meta-analysis — it is not a sign the study was flawed, simply that it alone did not have enough precision to rule out chance. A non-significant pooled result is more informative: it suggests that even after combining all available evidence, the true effect remains uncertain, which may reflect a genuinely small or absent effect, or simply that even the combined sample size remains too small.
Clinical vs Statistical Significance
A statistically significant pooled result only tells you the combined evidence is unlikely to reflect pure chance — it says nothing about whether the size of that effect actually matters to a patient. With enough pooled studies and a large enough combined sample size, even a tiny, clinically trivial effect can become statistically significant.
A meta-analysis pools 40,000 patients across 22 trials and reports MD = -1.2 mmHg (95% CI [-1.9, -0.5], p = 0.001) for systolic blood pressure with a new drug versus placebo. This is statistically significant — the CI excludes 0 — but a 1.2 mmHg reduction is very unlikely to be clinically meaningful for an individual patient's cardiovascular risk. Always look at the actual magnitude of the diamond's position, not only whether it crosses the null line.
Common Interpretation Mistakes
Mistake 1: Judging Only Whether the Diamond Crosses the Line
Reducing the whole plot to a binary "significant or not" ignores the actual magnitude of the pooled effect, its precision, and how consistent the individual studies were with each other.
Mistake 2: Ignoring Heterogeneity
Presenting a pooled estimate with high I² as if it were a single, well-agreed-upon answer glosses over the fact that the included studies may not be estimating the same true effect at all.
Mistake 3: Treating a Large Square as More Trustworthy Than a Small One
Square size reflects statistical weight (precision), not study quality — a large, poorly designed study can still receive a large square despite being at high risk of bias.
Mistake 4: Confusing the Scale for OR/RR/HR with the Scale for MD/SMD
Odds ratios, risk ratios, and hazard ratios are centered on 1 (no effect) and usually plotted on a logarithmic scale; mean differences and standardized mean differences are centered on 0 and plotted on a linear scale. Misreading which applies leads to misjudging distances on the plot.
Mistake 5: Assuming Statistical Significance Equals Clinical Importance
A very large pooled sample size can make a trivially small effect statistically significant, which does not make it clinically actionable.
Forest Plots for OR, RR, MD, SMD, and HR
The same forest plot layout is used for every effect measure in meta-analysis — only the line of no effect's value and the axis scale change.
| Effect Measure | Used For | Line of No Effect | Typical Scale |
|---|---|---|---|
| Odds Ratio (OR) | Case-control studies; binary outcomes in logistic regression | 1 | Logarithmic |
| Risk Ratio (RR) | Cohort studies, RCTs; binary outcomes, cumulative risk | 1 | Logarithmic |
| Mean Difference (MD) | Continuous outcomes measured on the same scale across studies | 0 | Linear |
| Standardized Mean Difference (SMD) | Continuous outcomes measured on different scales/instruments across studies | 0 | Linear |
| Hazard Ratio (HR) | Time-to-event (survival) outcomes, from Cox regression | 1 | Logarithmic |
Choosing between MD and SMD depends entirely on whether the underlying studies used the same measurement instrument. If every trial measured pain using the identical 0-10 numeric rating scale, MD is the natural, directly interpretable choice — a pooled MD of -1.5 means "1.5 points lower on that specific scale." If different trials used different pain scales entirely (a 0-10 scale in one study, a 0-100 visual analogue scale in another), those raw units cannot be pooled directly, and SMD re-expresses each study's effect in standard deviation units instead, sacrificing some direct interpretability in exchange for making otherwise incompatible studies combinable.
See our guides on odds ratio, relative risk vs odds ratio, standardized mean difference (Cohen's d), and hazard ratio for the individual-study version of each of these measures, before they are ever pooled into a forest plot.
Realistic Medical Example: Step by Step
Question: Does a new anti-emetic drug reduce postoperative nausea and vomiting (PONV) compared to standard care, based on the fixed-effect OR forest plot shown earlier?
Check the individual studies
All five squares sit to the left of OR = 1, suggesting a consistent direction of benefit even before pooling — a good sign of agreement between studies.
Check heterogeneity
I² = 0%, Chi² p = 0.54 — no meaningful heterogeneity detected, supporting the choice of a fixed-effect model and suggesting the studies are estimating a shared true effect.
Read the pooled diamond
OR = 0.64, 95% CI [0.53, 0.78] — entirely left of the line of no effect, so the pooled result is statistically significant.
Judge clinical significance
An OR of 0.64 represents a meaningful reduction in the odds of PONV, a common and distressing postoperative complication — plausibly large enough to matter clinically, not just statistically.
Write the conclusion
"Pooled analysis of five randomized trials showed the new anti-emetic significantly reduced the odds of postoperative nausea and vomiting compared to standard care (OR 0.64, 95% CI [0.53, 0.78], p < 0.001; I² = 0%)."
Practical Interpretation Checklist
Identify the effect measure and its null value
OR/RR/HR → line at 1; MD/SMD → line at 0.
Scan individual study direction
Are most squares on the same side of the null line, or scattered across both?
Check heterogeneity (I²)
Low (<25%) supports a fixed-effect model; moderate-to-high favors random-effects and more cautious interpretation.
Read the pooled diamond's position and width
Center = pooled estimate; width = pooled 95% CI.
Confirm statistical significance
Does the diamond touch the null line, or sit entirely on one side?
Judge clinical significance separately
Is the actual magnitude of the pooled estimate large enough to matter to a patient?
Note how many studies and how much total weight
Be more cautious with pooled results built from very few studies.
Frequently Asked Questions
Analyze the Studies Behind the Forest Plot
Use StatClinic's free calculators to compute the odds ratios, risk ratios, mean differences, and hazard ratios that feed into a meta-analysis — and get a journal-ready results sentence generated automatically. Free, no registration required.
Try StatClinic Free →